
UVA Acquires Two Bioprinters for Tissue, Organ Fabrication
The University of Virginia has acquired two new state-of-the-art three-dimensional bioprinters …mehr lesen »
The University of Virginia has acquired two new state-of-the-art three-dimensional bioprinters …mehr lesen »
An international study published in the journal Nature Communications points the way toward wider, …mehr lesen »
Rarely indeed do I start an article with a direct quote. This one however is so profound that it could potentially affect some seven billion people’s future health prospects:
“We also aim to integrate printed tissue-like materials with living tissues, and to print materials that themselves contain living cells. Our long-term goal is to develop a synthetic-tissue printer that a surgeon can use in the operating theatre. In ten years’ time, the use of pieces of synthetic tissue will be commonplace. The fabrication of complex synthetic organs is a more distant prospect.”
– Professor Hagan Bayley.
(…weiter auf 3dprintingindustry.com)
Hartmut Schwandt wird am Donnerstag bei der PRINT3Dfuture-Konferenz in Wien erklären, wie menschliches Gewebe mit Hilfe von 3D-Druckern in Form gebracht werden kann.
(…weiter auf futurezone.at)
For the first time, researchers at the Sabancı University in Turkey have 3D printed macro-vascular tissue constructs by using self-supported live cells and MR data.
The ultimate goal of 3D Tissue and Organ Printing Group led by professor Bahattin Koç, Sabancı University Faculty of Engineering and Natural Sciences‘ Manufacturing Systems Program member, is to use 3D bio-printers to print anatomically correct parts of / or an entire tissue/organ by using the patient’s own regular cells or stem cells. As every item printed will be created from a culture of a patient’s own cells, the risk of transplant organ rejection may not be a problem anymore.
(…weiter auf 3ders.org)
)
(Quelle: Youtube / sabanciuniversity)
3D-bioprinting is an exciting new technology, which may one day lead to the fabrication of replacement human tissues on-demand for transplantation. A team of scientists at Swansea University in the UK are working on the design and development of a new generation 3D-bioprinting technology, together with the biological methods to make living tissues. With development then there is hope that this process can be used to make living constructs that can be used to replace damaged or diseased tissues. This is being focused towards producing lost tissue of the knee or hip as a result of arthritis and for such applications as abdominal, tracheal and breast reconstruction following cancer. This next step in the development of this process could one day transform the field of reconstructive medicine.
(…weiter auf 3ders.org)
Researchers at Brigham and Women’s Hospital (BWH) and Carnegie Mellon University have introduced a unique micro-robotic technique to assemble the components of complex materials, the foundation of tissue engineering and 3D printing.
(…weiter auf brighamandwomens.org)
Utrecht’s experimental tissue factory aims to use research and 3D printing technology to break new ground in biofabrication and bring living, 3D-printed cartilage one step closer to becoming a reality.
The experimental tissue factory is currently being developed by Utrecht Life Sciences which is an open innovation network in the Netherlands, uniting Utrecht University, University Medical Center Utrecht, government, and business. The factory will consist of two cleanrooms where 3D bioprinters and cell culture facilities are installed and will focus on orthopedic 3D printing applications such as the repair of bone and cartilage.
(…weiter auf 3ders.org)
Bioprinting ist ein Verfahren bei dem mit Hilfe von 3D-Druckern organisches Gewebe reproduziert werden kann. So lassen sich Schicht um Schicht maßgeschneiderte Gewebe herstellen wie z.B. Nasen oder Ohren. Durch die Verarbeitung embryonaler Stammzellen eröffnen sich für diese Sektor völlig neuartige Wachstumsmöglichkeiten. 3D-Bioprinting wird nicht nur die kosmetische Chirurgie und das Essensdesign revolutionieren, sondern vor allem den Markt für Prothesen, den Markt für Herzklappen, den Robotikmarkt, die Transplantationsmedizin und das Anti-Aging beeinflussen.
(…weiter auf heise.de/tp)
Das börsennotierte Biotech-Unternehmen Organovo hat große Pläne: In Zukunft sollen Patienten dringend benötigte Organe einfach per Knopfdruck aus dem 3D-Drucker bekommen. Schon heute kann Organovo auf diese Weise lebendes Leber-Gewebe erzeugen.
(…weiter auf finanzen100.de)
Wir setzen für unseren Internetauftritt sog. Cookies ein. Durch Einstellungen in Ihrem Browser können Sie die weitere Verwendung von Cookies deaktivieren. Weitere Informationen zu Cookies finden Sie in unserer Datenschutzerklärung
Die Cookie-Einstellungen auf dieser Website sind auf "Cookies zulassen" eingestellt, um das beste Surferlebnis zu ermöglichen. Wenn du diese Website ohne Änderung der Cookie-Einstellungen verwendest oder auf "Akzeptieren" klickst, erklärst du sich damit einverstanden.